Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 4 institutions in 3 countries.
Kapambwe MwapeEnteric Disease and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.
Cynthia MubangaEnteric Disease and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.ORCID 0000-0001-7557-6352
Obvious Nchimunya ChilyabanyamaEnteric Disease and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.ORCID 0000-0003-3593-1895
Kennedy ChibesaEnteric Disease and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.ORCID 0000-0002-9539-4756
Caroline Cleopatra ChisengaEnteric Disease and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.
Suwilanji SilwambaEnteric Disease and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.
Arlo RandallAntigen Discovery Inc., 1 Technology Dr., STE E309, Irvine, CA 92618, USA.
Xiaowu LiangAntigen Discovery Inc., 1 Technology Dr., STE E309, Irvine, CA 92618, USA.
Tobias George BarnardWater and Health Research Center, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.ORCID 0000-0002-6831-1361
Michelo SimuyandiEnteric Disease and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.ORCID 0000-0002-7348-2835
Roma ChilengiEnteric Disease and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.
Centre for Infectious Disease Research in Zambia · ZMAntigen Discovery (United States) · USNational Health Laboratory Service · ZAUniversity of Johannesburg · ZA
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Diarrhoeagenic
Indexed as
cross-reactivitydiarrhoeadiarrhoeagenic E. coliETVAX vaccinemicroarrayvaccines
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic · full record | OpenQuestion